Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims
Daniel H. Solomon, Chih‐Chin Liu, I‐Hsin Kuo, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 9, pp. 1674-1679
Open Access | Times Cited: 132

Showing 26-50 of 132 citing articles:

Atherosclerosis and inflammation. New therapeutic approaches
Juan Pedro‐Botet, Elisenda Climent, David Benaiges
Medicina Clínica (English Edition) (2020) Vol. 155, Iss. 6, pp. 256-262
Closed Access | Times Cited: 53
Colchicine for the treatment of the spectrum of cardiovascular diseases: current evidence and ongoing perspectives
Massimo Imazio, Cosimo Agrimi, Laura Cescon, et al.
Journal of Cardiovascular Medicine (2024) Vol. 25, Iss. 9, pp. 653-663
Open Access | Times Cited: 7
Anti-inflammatory therapy for cardiovascular disease
Constantine E. Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 7, pp. 147-147
Open Access | Times Cited: 53
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein
Aernoud T.L. Fiolet, Max J. M. Silvis, Tjerk S.J. Opstal, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237665-e0237665
Open Access | Times Cited: 43
A glance into the future of gout
Francisca Sivera, Mariano Andrés, Nicola Dalbeth
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 27
Identification and treatment of the vulnerable coronary plaque
Anna van Veelen, N M R Van Der Sangen, José P.S. Henriques, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions
Jürgen Braun, Klaus Krüger, Bernhard Manger, et al.
Deutsches Ärzteblatt international (2017)
Open Access | Times Cited: 42
Gout and cardiovascular disease: crystallized confusion
Aryeh M. Abeles, Michael H. Pillinger
Current Opinion in Rheumatology (2018) Vol. 31, Iss. 2, pp. 118-124
Closed Access | Times Cited: 39
Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes
Subuhi Kaul, Manasvi Gupta, Dhrubajyoti Bandyopadhyay, et al.
American Journal of Cardiovascular Drugs (2020) Vol. 21, Iss. 5, pp. 499-512
Open Access | Times Cited: 34
Non-Coding RNAs in Regulating Plaque Progression and Remodeling of Extracellular Matrix in Atherosclerosis
Drishtant Singh, Vikrant Rai, Devendra K. Agrawal
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13731-13731
Open Access | Times Cited: 20
Gout and Cardiovascular Disease: Mechanisms, Risk Estimations, and the Impact of Therapies
Mariano Andrés
Gout Urate and Crystal Deposition Disease (2023) Vol. 1, Iss. 3, pp. 152-166
Open Access | Times Cited: 13
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
Giovanni Cimmino, Francesco S. Loffredo, Gennaro De Rosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2483-2483
Open Access | Times Cited: 12
Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation
Robert Zhang, Brittany Weber, Diego Araiza‐Garaygordobil, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 5, pp. 423-434
Closed Access | Times Cited: 4
Colchicine for Stroke Prevention: A Systematic Review and Meta-analysis
Chinmay Khandkar, Kaivan Vaidya, Sanjay Patel
Clinical Therapeutics (2019) Vol. 41, Iss. 3, pp. 582-590.e3
Closed Access | Times Cited: 33
Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational Study
Zoë Vincent, Greg Gamble, Meaghan E House, et al.
The Journal of Rheumatology (2016) Vol. 44, Iss. 3, pp. 368-373
Closed Access | Times Cited: 32
COVID-19 and the Heart and Vasculature
Bernard Kadosh, Michael Garshick, Juan Gaztañaga, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 9, pp. 2045-2053
Open Access | Times Cited: 28
Colchicine for the treatment of cardiovascular diseases: old drug, new targets
Alessandro Andreis, Massimo Imazio, Gaetano Maria De Ferrari
Journal of Cardiovascular Medicine (2020) Vol. 22, Iss. 1, pp. 1-8
Closed Access | Times Cited: 28
WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study
Atsuhiko Kawabe, Takanori Yasu, Takeshi Morimoto, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 5, pp. 3748-3759
Open Access | Times Cited: 27
Anti-inflammatory Therapy for Coronary Atherosclerotic Heart Disease: Unanswered Questions Behind Existing Successes
Jun Ma, Xiaoping Chen
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 26
Review: Gout: A Roadmap to Approaches for Improving Global Outcomes
Nicola Dalbeth, Hyon K. Choi, Robert Terkeltaub
Arthritis & Rheumatology (2016) Vol. 69, Iss. 1, pp. 22-34
Open Access | Times Cited: 29
Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta‐analysis
Jufen Zhang, Riet Dierckx, Kevin Mohee, et al.
ESC Heart Failure (2016) Vol. 4, Iss. 1, pp. 40-45
Open Access | Times Cited: 28
Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout
Binita Shah, Michael Toprover, Daria B. Crittenden, et al.
Canadian Journal of Cardiology (2020) Vol. 36, Iss. 11, pp. 1722-1728
Open Access | Times Cited: 25
Development and clinical translation of P2X7 receptor antagonists: A potential therapeutic target in coronary artery disease?
Elijah Genetzakis, Jayson Gilchrist, Michael Kassiou, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108228-108228
Closed Access | Times Cited: 15
Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout
Margaret Noyes Essex, Markay Hopps, E. Jay Bienen, et al.
JCR Journal of Clinical Rheumatology (2017) Vol. 23, Iss. 3, pp. 160-166
Closed Access | Times Cited: 27
Colchicine in Stable Coronary Artery Disease
Aernoud T.L. Fiolet, Stefan M. Nidorf, Arend Mosterd, et al.
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 30-40
Open Access | Times Cited: 26

Scroll to top